10-Q Filing

GILEAD SCIENCES, INC. CIK: 882095 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0000882095-21-000013`
Period End Date	20210331
Filing Date	20210506
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	gild-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 36 Cash Flow Statement 70 Stockholders Equity 28 Comprehensive Income 24

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.05B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.07B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.63B	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00B	USD	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$1.41B	USD	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$1.60B	USD	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$4.89B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.92B	USD	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$1.68B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventories	`InventoryNet`	$1.78B	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.01B	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	5.60B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	5.60B	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.91B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.00B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.25B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.25B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.28B	USD	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.97B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.99B	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$579.00M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$502.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$34.78B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.13B	USD	Point-in-time
Goodwill	`Goodwill`	$8.33B	USD	Point-in-time
Goodwill	`Goodwill`	$8.11B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$5.71B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$5.53B	USD	Point-in-time
Total assets	`Assets`	$68.41B	USD	Point-in-time
Total assets	`Assets`	$67.49B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$844.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$570.00M	USD	Point-in-time
Accrued government and other rebates	`AccruedGovernmentAndOtherRebates`	$3.37B	USD	Point-in-time
Accrued government and other rebates	`AccruedGovernmentAndOtherRebates`	$3.46B	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$3.51B	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$4.34B	USD	Point-in-time
Current portion of long-term debt and other obligations, net	`DebtCurrent`	$2.76B	USD	Point-in-time
Current portion of long-term debt and other obligations, net	`DebtCurrent`	$2.26B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.71B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.40B	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$28.64B	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$27.91B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$5.02B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$5.02B	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$4.46B	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$3.91B	USD	Point-in-time
Other long-term obligations	`OtherLiabilitiesNoncurrent`	$1.21B	USD	Point-in-time
Other long-term obligations	`OtherLiabilitiesNoncurrent`	$1.43B	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,254 shares issued and outstanding	`CommonStockValue`	$1.00M	USD	Point-in-time
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,254 shares issued and outstanding	`CommonStockValue`	$1.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.88B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.09B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-60.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$38.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$14.38B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$14.82B	USD	Point-in-time
Total Gilead stockholders equity	`StockholdersEquity`	$18.95B	USD	Point-in-time
Total Gilead stockholders equity	`StockholdersEquity`	$18.20B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$12.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$19.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.18B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.22B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.65B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.96B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$68.41B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$67.49B	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.42B	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.55B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$969.00M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$1.36B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.05B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.00B	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	$62.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	$97.00M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.05B	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.08B	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.53B	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.15B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$2.89B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$2.40B	USD	1 Quarter
Interest expense	`InterestExpense`	$241.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$257.00M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-369.00M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-158.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.26B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.00B	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$542.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$465.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.54B	USD	1 Quarter
Net income	`ProfitLoss`	$1.72B	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-13.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-7.00M	USD	1 Quarter
Net income attributable to Gilead	`NetIncomeLoss`	$1.55B	USD	1 Quarter
Net income attributable to Gilead	`NetIncomeLoss`	$1.73B	USD	1 Quarter
Net income per share attributable to Gilead common stockholders - basic (in dollars per share)	`EarningsPerShareBasic`	$1.23	USD	1 Quarter
Net income per share attributable to Gilead common stockholders - basic (in dollars per share)	`EarningsPerShareBasic`	$1.38	USD	1 Quarter
Shares used in per share calculation - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Shares used in per share calculation - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Net income per share attributable to Gilead common stockholders - diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.37	USD	1 Quarter
Net income per share attributable to Gilead common stockholders - diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.22	USD	1 Quarter
Shares used in per share calculation - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	1 Quarter
Shares used in per share calculation - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.54B	USD	1 Quarter
Net income	`ProfitLoss`	$1.72B	USD	1 Quarter
Depreciation expense	`Depreciation`	$78.00M	USD	1 Quarter
Depreciation expense	`Depreciation`	$68.00M	USD	1 Quarter
Amortization expense	`AdjustmentForAmortization`	$395.00M	USD	1 Quarter
Amortization expense	`AdjustmentForAmortization`	$281.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$141.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$139.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	$62.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	$97.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$71.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$56.00M	USD	1 Quarter
Net losses from equity securities	`IncreaseDecreaseInEquitySecuritiesFvNi`	$-283.00M	USD	1 Quarter
Net losses from equity securities	`IncreaseDecreaseInEquitySecuritiesFvNi`	$-351.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-201.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-73.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$376.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-975.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$69.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-15.00M	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-46.00M	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.00M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-109.00M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-253.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-127.00M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-316.00M	USD	1 Quarter
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-550.00M	USD	1 Quarter
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-738.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.61B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.44B	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$13.16B	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$931.00M	USD	1 Quarter
Proceeds from sales of marketable debt securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$9.66B	USD	1 Quarter
Proceeds from sales of marketable debt securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$60.00M	USD	1 Quarter
Proceeds from maturities of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$619.00M	USD	1 Quarter
Proceeds from maturities of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$3.45B	USD	1 Quarter
Acquisitions, including in-process research and development, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.25B	USD	1 Quarter
Acquisitions, including in-process research and development, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$63.00M	USD	1 Quarter
Purchases of equity securities	`PaymentsToAcquireOtherInvestments`	$279.00M	USD	1 Quarter
Purchases of equity securities	`PaymentsToAcquireOtherInvestments`	$8.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$171.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$165.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$49.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$91.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-344.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.04B	USD	1 Quarter
Proceeds from issuances of common stock	`ProceedsFromIssuanceOfCommonStock`	$88.00M	USD	1 Quarter
Proceeds from issuances of common stock	`ProceedsFromIssuanceOfCommonStock`	$177.00M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$309.00M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.33B	USD	1 Quarter
Repayments of debt and other obligations	`RepaymentsOfDebt`	$1.25B	USD	1 Quarter
Repayments of debt and other obligations	`RepaymentsOfDebt`	$500.00M	USD	1 Quarter
Payments of dividends	`PaymentsOfDividends`	$917.00M	USD	1 Quarter
Payments of dividends	`PaymentsOfDividends`	$874.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-89.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-86.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.48B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.61B	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-61.00M	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-23.00M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.58B	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.93B	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.05B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.07B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.63B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.05B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.07B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.63B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00B	USD	Point-in-time

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Common stock, dividends declared (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.68	USD	1 Quarter
Common stock, dividends declared (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.71	USD	1 Quarter
Beginning balance (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.18B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.22B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.65B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.96B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$1.54B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.72B	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$98.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-39.00M	USD	1 Quarter
Issuances under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$66.00M	USD	1 Quarter
Issuances under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$76.00M	USD	1 Quarter
Issuances under equity incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$12.00M	USD	1 Quarter
Issuances under equity incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$111.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$141.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$140.00M	USD	1 Quarter
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$1.41B	USD	1 Quarter
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$399.00M	USD	1 Quarter
Dividends declared	`Dividends`	$867.00M	USD	1 Quarter
Dividends declared	`Dividends`	$906.00M	USD	1 Quarter
Ending balance (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	1.25B	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.18B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.22B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.65B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.96B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.54B	USD	1 Quarter
Net income	`ProfitLoss`	$1.72B	USD	1 Quarter
Net foreign currency translation gain (loss), net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.00M	USD	1 Quarter
Net foreign currency translation gain (loss), net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-39.00M	USD	1 Quarter
Net unrealized loss, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax`	$-23.00M	USD	1 Quarter
Net unrealized loss, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax`	$-2.00M	USD	1 Quarter
Reclassifications to net income, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Reclassifications to net income, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$11.00M	USD	1 Quarter
Net change	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-34.00M	USD	1 Quarter
Net change	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Net unrealized gain, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$57.00M	USD	1 Quarter
Net unrealized gain, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$68.00M	USD	1 Quarter
Reclassifications to net income, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$-22.00M	USD	1 Quarter
Reclassifications to net income, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$23.00M	USD	1 Quarter
Net change	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$34.00M	USD	1 Quarter
Net change	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$90.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$98.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-39.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.82B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.50B	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-13.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-7.00M	USD	1 Quarter
Comprehensive income attributable to Gilead	`ComprehensiveIncomeNetOfTax`	$1.51B	USD	1 Quarter
Comprehensive income attributable to Gilead	`ComprehensiveIncomeNetOfTax`	$1.83B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.